Black Diamond (BDTX) Director Raman Prakash Receives 6,801 Shares
$BDTX · Black Diamond Therapeutics, Inc.Research Summary
AI-generated summary of this SEC filing
Black Diamond (BDTX) Director Raman Prakash Receives 6,801 Shares
What Happened
Raman Prakash, a non-employee director of Black Diamond Therapeutics (BDTX), received 6,801 shares of common stock on 2026-09-18 as an award/compensation. The shares were valued at $1.93 each (based on the 2026-09-17 closing price), for a total reported value of $13,126. This was an equity grant issued under the company’s non-employee director compensation policy — a routine compensation event rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-09-18 (reported on Form 4 filed 2026-09-21).
- Transaction type/code: Award/Grant (A).
- Shares received: 6,801 at $1.93 per share; total value ≈ $13,126.
- Footnotes: (1) Shares issued under the Sixth Amended and Restated Non-Employee Director Compensation Policy, elected in lieu of cash. (2) Price is based on the 2026-09-17 closing market price.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Timeliness: Filing dated 2026-09-21 for a 2026-09-18 transaction — appears to be filed within the normal Form 4 reporting window (timely).
Context
Non-employee directors commonly receive equity awards as part of routine compensation; such grants are standard and do not by themselves indicate a change in insider sentiment about the company. The dollar amount here (~$13k) is modest; for investors, outright purchases or sales by insiders typically carry more direct informational value than routine compensation awards.